Kliogest (Norethisterone Acetate, Estradiol)

The estradiol component provides negative feedback to the hypothalamic‑pituitary axis, reducing follicle‑stimulating hormone release, while norethisterone acetate acts as a progestogen to suppress the luteinising hormone surge. Together they inhibit ovulation and stabilise the endometrium, preventing pregnancy and regulating the menstrual cycle.

The specific dosing regimen for Kliogest is determined by the prescribing clinician based on the patient’s medical history, age, and therapeutic goals. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Kliogest is contraindicated during pregnancy because it is intended to prevent conception. Women who become pregnant while taking the product should discontinue use and seek medical advice. Limited data are available for breastfeeding; clinicians usually advise against use while nursing unless the benefits outweigh potential risks.

To order Kliogest, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Kliogest contains norethisterone acetate and estradiol, whereas many other combined pills use ethinyl‑estradiol as the estrogen component. Estradiol is a natural estrogen, which may be associated with a different side‑effect profile, but overall contraceptive efficacy is comparable when taken as directed.

Kliogest tablets should be stored at room temperature, below 25 °C, in the original blister pack or container. Protect them from excess moisture, heat and direct sunlight to maintain potency throughout the shelf life.

Kliogest is taken orally, usually once daily at the same time each day, as directed by the prescriber. It is commonly started on the first day of the menstrual period or as part of a prescribed cycle regimen.

Serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, severe hypertension, liver dysfunction, and rare allergic reactions. Patients should seek immediate medical attention if they experience unexplained leg pain, shortness of breath, severe headache, jaundice, or swelling of the face and throat.

Kliogest is contraindicated in women with a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, known hypersensitivity to its components, or who are pregnant. It should also be avoided by smokers over 35 years of age due to increased cardiovascular risk.